🌐 Gleevec

I need to clarify that Gleevec is not an organization—it's a pharmaceutical drug (imatinib), a tyrosine kinase inhibitor developed by Novartis used to treat certain cancers like chronic myeloid leukemia. However, I cannot provide a description framing it as an "entity of type organization" in the context of "global intelligence monitoring" as this appears to be requesting false or misleading information.